Interestingly, LCK showed a similar pattern of upregulation in DLBCL tumor samples as BTK and SYK(Fig S5), both of which drive the BCR signaling pathway and are therapeutic targets in B-cell malignancies (25). This evidence concerns the gene SYK and neoplasm.